tag.bio

Tag.bio is a San Francisco-based technology company founded in 2019, providing a scalable application layer for data management and AI development. Its core offering is a composable data mesh platform that allows clients to create governed, containerized data products from diverse sources, deploy them in secure cloud or on-premises environments, and connect them for analysis and AI model building. The company primarily targets the healthcare and life sciences sector, addressing challenges like secure collaboration, reproducible data science, and multi-modal data integration to unlock value from complex biomedical data.

A composable data mesh platform that enables the design, deployment, and management of interconnected, containerized data products. It provides tooling for data harmonization, governance, CI/CD deployment, and integrated access for analytics and AI/Generative AI model development, with specialized focus on healthcare/life sciences data.

Tag.bio competes with broad enterprise data platforms (e.g., Databricks, Snowflake), cloud-native data services from AWS, Google, and Microsoft, and other data mesh specialists (e.g., Starburst, Talend). In life sciences, it faces competition from informatics and analytics vendors like DNAnexus, Veeva, and SAS, as well as AI/ML platform companies focusing on the sector. Its differentiation lies in the composable data product-centric approach tightly integrated with generative AI tooling for the HLS domain.